Medicare Advantage
  
MPNewsFlashTopicPub
  
  
MPPurposePub
  
  
11/25/2020
Veklury® (remdesivir) and Bamlanivimab® (LY-CoV555) for COVID-19 Treatment for Medicare Advantage Members
0

To Communicate the Company's coverage​ position for Veklury® (remdesivir) and Bamlanivimab® (LY-CoV555) for COVID-19 treatment for the Company’s Medicare Advantage products. 

This communication addressing Treatments for SARS-CoV-2 (Coronavirus Disease 2019 (COVID-19)) is effective from October 22, 2020 and for the duration of the Public Health Emergency.​ 

Veklury® (remdesivir) and Bamlanivimab® (LY-CoV555) for COVID-19 Treatment for Medicare Advantage Members61635c1f-5e9e-46b6-9c93-346c2e258180
11/18/2020
Telehealth Services for Medicare Advantage Members (Updated November 18, 2020)
0
The purpose of this communication is to provide advance notice regarding coverage for telehealth services for our Medicare Advantage members in response to Coronavirus Disease 2019 (COVID-19). 
Telehealth Services for Medicare Advantage Members (Updated November 18, 2020)2df52a2e-2005-4d63-ae28-26f0dc12ffa6
10/6/2020
Testing for SARS-CoV-2 (Coronavirus Disease 2019 (COVID-19)) for Independence Medicare Advantage Members
1
The purpose of this News Article is to provide advance notice regarding information and procedure and diagnosis codes related to testing for SARS-CoV-2 (Coronavirus Disease 2019 (COVID-19)) for Independence Medicare Advantage members.

Testing for SARS-CoV-2 (Coronavirus Disease 2019 (COVID-19)) for Independence Medicare Advantage Membersc37f6ca4-79a7-4de1-859b-aff7c3ad9f86
10/1/2020
10/1/2020 CPT & HCPCS Quarterly Code Update Coverage Determinations for Medicare Advantage Products
0.1
The intent of this article is to communicate Medicare Advantage Product coverage determinations for services identified through the Quarterly Code Update process. The procedure codes that represent these services will become effective on 10/1/2020, unless otherwise noted. 

For more information related to these services, please refer to specific policies when applicable.​



10/1/2020 CPT & HCPCS Quarterly Code Update Coverage Determinations for Medicare Advantage Productseaaa732d-9e1b-4325-a3d9-2891b122930a
7/17/2020
Respiratory Equipment and Related Supplies (updated July 17, 2020)
1
The purpose of this News Article is to provide advance notice during the COVID-19 outbreak related to respiratory equipment and related supplies.
Respiratory Equipment and Related Supplies (updated July 17, 2020)9501C49E786EA93E852585A7007B12E0
7/17/2020
Consumer Grade Pulse Oximetry Devices For Use In The Home Setting
1
The purpose of this News Article is to provide advance notice during the COVID-19 outbreak related to the coverage of consumer grade pulse oximetry devices for use in the home setting.
Consumer Grade Pulse Oximetry Devices For Use In The Home Setting6C97385C22DEF1EC852585A7007B19D5
7/1/2020
7/1/2020 CPT & HCPCS Quarterly Code Update Coverage Determinations for Medicare Advantage Products
1
7/1/2020 CPT & HCPCS Quarterly Code Update Coverage Determinations for Medicare Advantage ProductsBC325E22B96FD1D585258598006632FB
6/30/2020
​Waiver of certain requirements during COVID-19 outbreak related to Durable Medical Equipment (DME), prosthetics, orthotics, and supplies for Medicare Advantage members (updated June 30, 2020)
1
The purpose of this News Article is to provide advance notice regarding the temporary waiver of certain requirements for Durable Medical Equipment (DME), as well as prosthetics, orthotics, and supplies in response to Coronavirus Disease 2019 (COVID-19).
Waiver of certain requirements during COVID-19 outbreak related to Durable Medical Equipment (DME), prosthetics, orthotics, and supplies for Medicare Advantage members (updated June 30, 2020)731A7A410AA02BF08525858B0060F43F
5/12/2020
Pharmacologic Nuclear Stress Testing in Response to COVID-19 for Medicare Advantage Members
1
The purpose of this News Article is to provide advance notice regarding the use of pharmacologic stress testing with nuclear imaging in response to the Public Health Emergency (PHE) for the COVID-19 pandemic.
Pharmacologic Nuclear Stress Testing in Response to COVID-19 for Medicare Advantage Members6061365DEA093EF78525856500743BFA
5/8/2020
Computed tomography (CT) chest imaging for diagnosis of COVID-19 pneumonia
1
The purpose of this News Article is to provide advance notice regarding the addition of CT Chest imaging for diagnosis of COVID-19 pneumonia for Medicare Advantage members.
Computed tomography (CT) chest imaging for diagnosis of COVID-19 pneumonia5E10A8923324CD3985258561007D6C71
1 - 10Next